New fat-burning diabetes pill protects muscle and appetite Date: December 7, 2025 Source: Karolinska Institutet Summary: Researchers have developed a new oral drug that boosts metabolic activity in muscle rather than altering appetite like GLP-1 drugs
Lyrica was approved by the FDA in December 2004 for adjunctive therapy in partial-onset seizures and was subsequently approved for fibromyalgia and diabetic peripheral neuropathy
Implementing good sleep hygiene practices is fundamental to managing sleep disturbances: Maintain a consistent sleep-wake schedule, even on weekends Create a comfortable sleep environment (cool, dark, and quiet) Avoid caffeine and alcohol in the evening Avoid large meals in the evening Limit screen time for at least one hour before bed Engage in regular physical activity, but not close to bedtime Practice relaxation techniques such as deep breathing or meditation Dietary modifications may also prove helpful
Microbiology and Molecular Biology Reviews
Share this newsletter with a friend and invite them to subscribe here.
doi:10.1016/j.aimed.2020.07.006 123 Alamdari, D
